A Study of Psilocybin in Adult Participants with Treatment Resistant Depression

  • Ages 18+
  • Diagnosis of single episode or recurrent MDD
  • Nonresponsive to 2, 3, or 4 antidepressants in current episode
  • Willing to discontinue antidepressant treatments
  • If you have been hospitalized or have tried non-medication based treatments you may not qualify for the trial
  • If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial
  • Method of Administration :  Oral / Capsule
    • Length/Duration:
    • 16 weeks total
    • Up to 3 treatment sessions and bi weekly follow up visits included
    • Location:  721 North Magnolia Avenue, Orlando FL 32803
    • Compensation: $102 / visit
    • Participants may:
      • See a doctor or medical staff at no cost
      • Have access to trial medications
      • Receive compensation for time and travel

Learn More About Participating in a Study

  • This field is for validation purposes and should be left unchanged.